July 25, 2025

PureTech Health plc (PRTC) Stock Analysis: Exploring a Potential 142% Upside in Biotechnology

Investors are taking a closer look at PureTech Health plc (NASDAQ: PRTC), a dynamic player in the biotechnology sector with a promising pipeline of therapeutic innovations. This Boston-based company is..

Prothena Corporation (PRTA) Stock Analysis: Uncovering the 262% Upside Potential in Biotech Innovation

Prothena Corporation plc (NASDAQ: PRTA), a pioneering force in the biotechnology sector, presents a compelling case for investors with its significant upside potential of 262.47%. Based in Ireland, Prothena is..

Geron Corporation (GERN) Stock Analysis: Exploring a Remarkable 164.76% Potential Upside in Biotech

For investors with a keen interest in the biotechnology sector, Geron Corporation (NASDAQ: GERN) presents a compelling case, especially with its striking potential upside of 164.76%. With a focus on..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: Unveiling a 162.92% Potential Upside in Mental Health Biotech

ATAI Life Sciences N.V. (NASDAQ: ATAI) stands at the forefront of the biotechnology sector, with a unique focus on developing innovative treatments for mental health disorders. Headquartered in Berlin, Germany,..

Myriad Genetics, Inc. (MYGN) Stock Analysis: A Deep Dive into the 60.46% Potential Upside for Investors

Myriad Genetics, Inc. (NASDAQ: MYGN), a pivotal player in the healthcare sector, stands at the intersection of molecular diagnostics and precision medicine. Headquartered in Salt Lake City, Utah, the company..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring a 36.94% Potential Upside in the Healthcare Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is currently a focal point for investors eyeing the healthcare sector. With a market capitalization of approximately $441.33 million, this Boca Raton-based company offers..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a Potential 210% Upside in the Biotech Sector

Vir Biotechnology, Inc. (NASDAQ: VIR) is capturing attention in the biotech investment arena with its compelling potential upside of 210.33%, as indicated by analyst ratings. This clinical-stage biopharmaceutical company, headquartered..

RxSight, Inc. (RXST) Stock Analysis: A Look at the 53.93% Potential Upside and Analyst Consensus

RxSight, Inc. (NASDAQ: RXST), a commercial-stage medical technology company, is making waves in the healthcare sector with its innovative approach to cataract surgery. Specializing in the development and sale of..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Growth in a Complex Market

For investors with a keen eye on the healthcare sector, Sonida Senior Living, Inc. (SNDA) represents a compelling opportunity in the niche of senior housing. Based in Dallas, Texas, the..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Exploring a 60% Potential Upside in the Pediatric Orthopedic Sector

OrthoPediatrics Corp. (NASDAQ: KIDS) stands out in the healthcare sector, specifically within the medical devices industry, as a company focused on the unique needs of pediatric orthopedic patients. With a..

Opthea Limited (OPT)

⚠️ No article content returned.

..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Healthcare Innovator with 93% Upside Potential

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a dynamic player in the healthcare sector specializing in treatments for rare diseases, presents a tantalizing opportunity for investors seeking high-growth potential. With its market..

Celcuity Inc. (CELC) Stock Analysis: A Promising Biotech with Over 100% Potential Upside

Individual investors eyeing opportunities in the biotechnology sector may find Celcuity Inc. (NASDAQ: CELC) an intriguing prospect. This Minneapolis-based company, with a market capitalization of $532.02 million, is on a..

Simulations Plus, Inc. (SLP) Stock Analysis: A 93% Potential Upside Awaits Investors

Simulations Plus, Inc. (NASDAQ: SLP), a leader in the healthcare sector, specifically within the health information services industry, offers an intriguing investment opportunity highlighted by a notable 93.09% potential upside,..

Day One Biopharmaceuticals (DAWN) Stock Analysis: Is a 264% Upside Within Reach?

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is capturing investor attention with its ambitious goal of transforming the treatment landscape for childhood and adult diseases through innovative biotechnology solutions. The company’s..

Evolus, Inc. (EOLS) Stock Analysis: Unpacking the 144% Potential Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS) stands at a fascinating intersection of opportunity and potential within the healthcare sector. Specializing in the aesthetic market, this Newport Beach-based company is gaining traction with..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Unveiling a 170% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) stands out in the volatile biotechnology sector, capturing the attention of investors with a staggering potential upside of 170.69%. This clinical-stage biopharmaceutical company is making..

Cronos Group Inc. (CRON) Stock Analysis: Unpacking the 27.6% Revenue Growth in a Competitive Cannabis Market

Investors eyeing opportunities in the cannabis sector should consider the recent performance and future potential of Cronos Group Inc. (NASDAQ: CRON). This Canadian-based company, with a market cap of $798.97..

Personalis, Inc. (PSNL) Stock Analysis: Navigating Growth in Cancer Genomics with a 6.45% Potential Upside

Personalis, Inc. (NASDAQ: PSNL) stands at the frontier of the burgeoning cancer genomics sector, offering investors a unique opportunity to tap into a rapidly evolving market. Headquartered in Fremont, California,..

COMPASS Pathways Plc (CMPS) Stock Analysis: Exploring a Potential 263% Upside in the Mental Health Sector

COMPASS Pathways Plc (NASDAQ: CMPS) is making waves in the healthcare sector, focusing on the burgeoning field of mental health treatment. With a market capitalization of $408.87 million, this UK-based..

Search

Funds

July 25, 2025

Search

Funds

July 25, 2025

FTSE 100

Funds